The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Issues
Latest issue
Regular issues
Supplements
PCR Trials
All issues
Articles
Regular articles
Ahead of print
All articles
Topics
Coronary interventions
STEMI
NSTEMI
Stable CAD
Stents and scaffolds
Left main and multivessel disease
Bifurcation lesions
CTO
Other coronary interventions
Interventions for valvular disease
TAVI
Mitral valve replacement and repair
Tricuspid / Pulmonary valve
Other valvular and structural interventions
Interventions for heart failure
Acute heart failure
Chronic heart failure
Peripheral interventions
Below the knee
Abdominal aortic aneurysm
Iliac / Femoral / Popliteal
Other peripheral interventions
Interventions for hypertension
Renal artery angioplasty
Renal denervation
Other hypertension
Interventions for stroke
Carotid stenting
LAA closure
Ischaemic stroke
Other stroke interventions
Services
Subscribe
Advertise
Rights & permissions
Reprint-Eprint
Join our mailing list
About
Overview
Editorial board
Contact us
Author centre
Dominic J. Allocco
Showing 1-16 of 16 articles
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-year results of the ACURATE neo2 PMCF Study
Kim W,
Möllmann H,
Montorfano M,
Ellert-Gregersen J,
Rudolph TK,
Van Mieghem NM,
Hilker M,
Amat-Santos I,
Terkelsen CJ,
Petronio AS,
Stella P,
Götberg M,
Rück A,
Kasel AM,
Trillo R,
Appleby C,
Barbanti M,
Blanke P,
Asch FM,
Modolo R,
Allocco DJ,
Tamburino C
November 20, 2023 | 10.4244/EIJ-D-23-00823
Clinical outcomes of the ACURATE neo2 transcatheter heart valve: a prospective, multicentre, observational, post-market surveillance study
Kim W,
Tamburino C,
Möllmann H,
Montorfano M,
Ellert-Gregersen J,
Rudolph TK,
Van Mieghem NM,
Hilker M,
Amat-Santos I,
Terkelsen CJ,
Petronio AS,
Stella P,
Götberg M,
Rück A,
Kasel AM,
Trillo R,
Appleby C,
Barbanti M,
Blanke P,
Modolo R,
Allocco DJ,
Sondergaard L
May 12, 2023 | 10.4244/EIJ-D-22-00914
A multicentre, randomised controlled clinical study of drug-coated balloons for the treatment of coronary in-stent restenosis
Hamm C,
Dörr O,
Woehrle J,
Krackhardt F,
Ince H,
Zeus T,
Berland J,
Piot C,
Roubille F,
Schult I,
Allocco DJ,
Nef H
July 17, 2020 | 10.4244/EIJ-D-19-00051
Final results from the REPRISE I study: five-year clinical outcomes with the repositionable and fully retrievable LOTUS valve system
Gooley R,
Worthley S,
Whitbourn R,
Montarello J,
Newcomb A,
Allocco DJ,
Meredith I
December 7, 2018 | 10.4244/EIJ-D-18-00664
Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I,
Verheye S,
Dubois C,
Dens J,
Farah B,
Carrié D,
Walsh S,
Oldroyd K,
Varenne O,
El-Jack S,
Moreno R,
Christen T,
Allocco DJ
April 20, 2018 | 10.4244/EIJ-D-17-00529
A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study
Han Y,
Liu H,
Yang Y,
Zhang J,
Xu K,
Fu G,
Su X,
Jiang T,
Pang W,
Chen J,
Yuan Z,
Li H,
Wang H,
Hong T,
Liu H,
Sun F,
Allocco DJ,
Zhang M,
Dawkins K
November 20, 2017 | 10.4244/EIJ-D-17-00271
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients
Meredith I,
Dumonteil N,
Blackman D,
Tchétché D,
Walters D,
Hildick-Smith D,
Manoharan G,
Harnek J,
Worthley S,
Rioufol G,
Lefèvre T,
Modine T,
Van Mieghem NM,
Feldman T,
Allocco DJ,
Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01024
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort
Dumonteil N,
Meredith I,
Blackman D,
Tchétché D,
Hildick-Smith D,
Spence M,
Walters D,
Harnek J,
Worthley S,
Rioufol G,
Lefèvre T,
Modine T,
Van Mieghem NM,
Houle V,
Allocco DJ,
Dawkins K
September 20, 2017 | 10.4244/EIJ-D-16-01025
One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE)
Tamburino C,
Capodanno D,
Erglis A,
Menown I,
Horvath I,
Moreno R,
Gilbert T,
Crowley J,
Calabria P,
Allocco DJ,
Dawkins K
March 20, 2015 | 10.4244/EIJY15M01_01
Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study
Meredith I,
Worthley S,
Whitbourn R,
Antonis P,
Montarello J,
Newcomb A,
Lockwood S,
Haratani N,
Allocco DJ,
Dawkins K
March 20, 2014 | 10.4244/EIJV9I11A216
Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I,
Verheye S,
Weissman N,
Barragan P,
Scott D,
Valdés Chávarri M,
West N,
Kelbæk H,
Whitbourn R,
Walters D,
Kubica J,
Thuesen L,
Masotti M,
Banning A,
Sjogren I,
Stables R,
Allocco DJ,
Dawkins K
July 26, 2013 | 10.4244/EIJV9I3A52
Boston Scientific Lotus valve
Meredith I,
Hood K,
Haratani N,
Allocco DJ,
Dawkins K
September 30, 2012 | 10.4244/EIJV8SQA12
Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials
Kereiakes D,
Popma J,
Cannon L,
Kandzari D,
Kimmelstiel C,
Meredith I,
Teirstein P,
Verheye S,
Allocco DJ,
Dawkins K,
Stone G
June 27, 2012 | 10.4244/EIJV8I2A32
PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses
Meredith I,
Whitbourn R,
Scott D,
El-Jack S,
Zambahari R,
Stone G,
Teirstein P,
Starzyk R,
Allocco DJ,
Dawkins K
May 17, 2011 | 10.4244/EIJV7I1A15
First human use of the TAXUS Petal paclitaxel-eluting bifurcation stent
Ormiston J,
Lefèvre T,
Grube E,
Allocco DJ,
Dawkins K
May 25, 2010
Carotid artery revascularisation in high-surgical-risk patients with the NexStent and the FilterWire EX/EZ: 3-year results from the CABERNET trial
Hopkins L,
Myla S,
Grube E,
Eles G,
Dave R,
Jaff M,
Allocco DJ
April 12, 2010
1
Latest news
NEW ISSUE
The Bifurcation ARC consensus; impact of P2Y12 de-escalation in HBR; 5-year outcomes of the TARGET trial and more...
December 4, 2023
STATE-OF-THE-ART
Free access collection all year long
December 4, 2023
AHEAD OF PRINT
Poor improvement of post-PCI iFR in LAD
FREE ARTICLE - Mitsuaki Matsumura et al
November 30, 2023
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
PCR London Valves 2023
November 16, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023